Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
Plasma levels of estradiol and progesterone were investigated in women using daily vaginal pills containing 1 mg norethindrone and 50 mcg mestranol. Of 13 treatment cycles in ten women using one vaginal pill daily, six were ovulatory and seven anovulatory. All 12 cycles in ten women using two vaginal pills daily were anovulatory.
D000287:Administration, Topical; D000328:Adult; D004958:Estradiol / Q000097:blood; D005260:Female; D006801:Humans; D008656:Mestranol / Q000008:administration & dosage*; D009640:Norethindrone / Q000008:administration & dosage*; D010060:Ovulation / Q000187:drug effects*; D011374:Progesterone / Q000097:blood; D014621:Vagina
D011374:Progesterone; D004958:Estradiol; D008656:Mestranol; D009640:Norethindrone